Profile
IMUX VRTX ALNY REGN ARGX SGEN
Company Name Immunic, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $83.36M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.09K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Daniel Vitt Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
IMUX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
IMUX VRTX ALNY REGN ARGX SGEN
Last Close $0.845 $383.12 $453.56 $591.99 $736.76 $228.74
High 52 $1.83 $516.74 $482.13 $1145.03 $768 $228.74
Low 52 $0.66 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -53.83 % -25.86 % -5.93 % -48.3 % -4.07 % 0 %
Price vs. 52 Week Low 28.03 % 4.52 % 101.96 % 22.59 % 41.75 % 0 %
Total Return
IMUX VRTX ALNY REGN ARGX SGEN
1 Month Return -8.15 % -2.85 % -0.97 % 0.13 % 11.48 % 0 %
3 Month Return 17.36 % -13.1 % 46.45 % 16.14 % 35.9 % 0 %
6 Month Return -25.55 % -24.88 % 78.81 % -10.65 % 20.02 % 0 %
9 Month Return -15.5 % -3.56 % 84.79 % -15.65 % 18.1 % 0 %
YTD Return -15.5 % -4.86 % 92.75 % -16.89 % 19.8 % 0 %
1 Year Return -53.83 % -17.59 % 65.61 % -48.3 % 38.23 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IMUX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -662.88 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
IMUX VRTX ALNY REGN ARGX SGEN
Asset Growth -24.74 % -0.87 %
Gross Profit Growth -20.72 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -1.29 % -93.69 %
Net Income Growth -7.37 % -114.8 %
Net Income 3 Yeari Growth Per Share 74.43 % -122.89 %
Net Income 5 Yeari Growth Per Share 77.75 % -145.38 %
Net Income 10 Yeari Growth Per Share 98.75 % 33.84 %
Operating Income Growth 1.18 % -106.08 %
Operating Cash Flow Growth (CFG) -19.68 % -113.93 %
Operating 3 Year CFG 75.95 % -118.65 %
Operating 5 Year CFG 77.11 % -131.3 %
Operating 10 Year CFG 98.77 % 12.43 %
EPS Growth 52.61 % -114.8 %
EPS Diluted Growth 52.61 % -114.97 %
Book Value Per Share -71.82 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -96.58 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -97.57 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -99.89 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share -100 % -
Debt Growth -24.74 % 116.42 %
Free Cash Flow Growth -19.49 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
IMUX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -62.28 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -165.78 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -461.46 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -308.55 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 96.74 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -92337.72 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -9208.48 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 0.19 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.02 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 7.18 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.19 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.68 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.68 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 41.85 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -79079.82 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.15 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -9208.48 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.92 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -1.24 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -1.24 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
IMUX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.1B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
IMUX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.02B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.04B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
IMUX VRTX ALNY REGN ARGX SGEN
Net Income $-0.1B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.85
AARD Aardvark Therapeutics, Inc. Common Stock 10.89
ABCL AbCellera Biologics Inc. 4.51
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.38
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.26
ABPWW 0.041
ABSI Absci Corporation 2.61
ABUS Arbutus Biopharma Corporation 4.25
ABVC ABVC BioPharma, Inc. 2.84
ABVX Abivax SA American Depositary Shares 82.3
ACAD ACADIA Pharmaceuticals Inc. 24.42
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7948
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.82
ACIU AC Immune SA 2.45
ETFs With Exposure to IMUX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00011 328.44
IBB iShares Biotechnology ETF 0 142.72
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 145.4
BIB ProShares Ultra Nasdaq Biotechnology 0 58.094
VXF Vanguard Extended Market Index Fund 0.00095 212.09
IWC iShares Micro-Cap ETF 0.01873 149.04
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00019 111.72
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00019 111.7
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.68
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.67
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.67
IBBQ Invesco Nasdaq Biotechnology ETF 0 24.0485
DFAS Dimensional U.S. Small Cap ETF 0.00069355 69.01
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000754 38.63
VTSAX Vanguard Total Stock Market Index Fund 0.00011 159.89
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 7.02
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00095 161.01
VITSX Vanguard Total Stock Market Index Fund 0.00011 159.92
QQQS Invesco NASDAQ Future Gen 200 ETF 0.359 32.6202
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000132752 16.15
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00095 161.03
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 57.7
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VTS.AX Vanguard US Total Market Shares Index ETF 0.00011 496.7
VEMPX Vanguard Extended Market Index InstlPlus 0.00095 397.36
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00011 300
Unlock